carbostyril has been researched along with Palatal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blume, M; Brodt, HR; de Leuw, P; Kann, G; Schüttfort, G; Stephan, C; Wolf, T | 1 |
1 other study(ies) available for carbostyril and Palatal Neoplasms
| Article | Year |
|---|---|
Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Male; Palatal Neoplasms; Palate, Hard; Quinolones; Sarcoma, Kaposi; Treatment Outcome | 2016 |